A pan-JNK inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SR 3306

Item No. 45342

Technical Information
Formal Name
N-[4-[3-(6-methyl-3-pyridinyl)-1H-1,2,4-triazol-1-yl]phenyl]-4-[3-(4-morpholinyl)phenyl]-2-pyrimidinamine
CAS Number
1128096-91-2
Molecular Formula
C28H26N8O
Formula Weight
Purity
≥98%
A solid
DMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
CC1=CC=C(C=N1)C(N=C2)=NN2C(C=C3)=CC=C3NC4=NC=CC(C5=CC(N6CCOCC6)=CC=C5)=N4
InChi Code
InChI=1S/C28H26N8O/c1-20-5-6-22(18-30-20)27-31-19-36(34-27)24-9-7-23(8-10-24)32-28-29-12-11-26(33-28)21-3-2-4-25(17-21)35-13-15-37-16-14-35/h2-12,17-19H,13-16H2,1H3,(H,29,32,33)
InChi Key
QDMXVKKPYBGIAS-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    SR 3306 is a pan-JNK inhibitor (IC50s = 67, 283, and 159 nM for JNK1, JNK2, and JNK3, respectively).1 It is selective for JNK1-3 over p38 MAPK (IC50 = >20 µM). SR 3306 (300-1,000 nM) reduces cell death induced by N-methyl-4-phenylpyridinium (MPP+) in primary rat mesencephalic dopaminergic neurons. It reduces MPTP- or 6-OHDA-induced neurodegeneration of dopaminergic neurons in the mouse substantia nigra pars compacta.1,2 SR 3306 (10 mg/kg) decreases D-amphetamine-induced circling in rats in a 6-OHDA model of Parkinson’s disease.2 It also enhances leptin-induced STAT3 activation in the hypothalamus, reduces food intake, decreases body weight in diet-induced obese (DIO) mice when administered at a dose of 30 mg/kg.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chambers, J.W., Pachori, A., Howard, S., et alSmall molecule c-jun-N-terminal kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson’s disease. ACS Chem. Neurosci. 2(4), 198-206 (2011).

    2. Crocker, C.E., Khan, S., Cameron, M.D., et alJNK Inhibition protects dopamine neurons and provides behavioral improvement in a rat 6-hydroxydopamine model of Parkinson’s disease. ACS Chem. Neurosci. 2(4), 207-212 (2011).

    3. Gao, S., Howard, S., and LoGrasso, P.V. Pharmacological inhibition of c-Jun N-terminal kinase reduces food intake and sensitizes leptin’s anorectic signaling actions. Sci. Rep. 7, 41795 (2017).